Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreas | 74 | 2019 | 718 | 5.340 |
Why?
|
Pancreatic Neoplasms | 85 | 2024 | 5061 | 4.820 |
Why?
|
Carcinoma, Pancreatic Ductal | 27 | 2024 | 1724 | 3.470 |
Why?
|
Pancreatitis | 15 | 2019 | 267 | 2.580 |
Why?
|
Sincalide | 28 | 2012 | 37 | 2.520 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 14 | 2024 | 1331 | 2.310 |
Why?
|
Receptors, Cholecystokinin | 24 | 2008 | 29 | 2.010 |
Why?
|
NF-kappa B | 17 | 2018 | 1549 | 1.650 |
Why?
|
Acinar Cells | 7 | 2019 | 53 | 1.610 |
Why?
|
Calcium-Binding Proteins | 8 | 2013 | 545 | 1.600 |
Why?
|
Cholecystokinin | 23 | 2010 | 45 | 1.510 |
Why?
|
Neoplasm Proteins | 13 | 2016 | 3230 | 1.490 |
Why?
|
Receptors, Immunologic | 6 | 2012 | 309 | 1.410 |
Why?
|
Trypsin | 6 | 2019 | 140 | 1.400 |
Why?
|
Receptor for Advanced Glycation End Products | 10 | 2017 | 38 | 1.360 |
Why?
|
Antigens, Surface | 4 | 2016 | 295 | 1.160 |
Why?
|
Animals | 163 | 2024 | 59536 | 1.140 |
Why?
|
Genes, ras | 6 | 2016 | 667 | 1.120 |
Why?
|
Trypsinogen | 7 | 2019 | 8 | 1.090 |
Why?
|
Deoxycytidine | 8 | 2020 | 1353 | 1.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 32 | 2020 | 8873 | 1.060 |
Why?
|
Pancreatitis, Chronic | 7 | 2018 | 116 | 1.040 |
Why?
|
Pancreas, Exocrine | 6 | 2018 | 22 | 1.040 |
Why?
|
Receptors, Muscarinic | 10 | 1999 | 69 | 0.990 |
Why?
|
Mice | 82 | 2024 | 34495 | 0.870 |
Why?
|
Pancreatic Stellate Cells | 11 | 2018 | 76 | 0.840 |
Why?
|
Cell Line, Tumor | 42 | 2020 | 14551 | 0.840 |
Why?
|
Bombesin | 10 | 2007 | 15 | 0.840 |
Why?
|
Adenocarcinoma | 19 | 2013 | 7789 | 0.810 |
Why?
|
Mice, Nude | 23 | 2019 | 4307 | 0.810 |
Why?
|
Gene Expression | 14 | 2019 | 3570 | 0.800 |
Why?
|
Endoplasmic Reticulum | 3 | 2008 | 308 | 0.790 |
Why?
|
RNA, Messenger | 36 | 2015 | 6150 | 0.770 |
Why?
|
Amylases | 20 | 2008 | 66 | 0.770 |
Why?
|
Cromolyn Sodium | 2 | 2013 | 7 | 0.750 |
Why?
|
RNA, Small Interfering | 13 | 2019 | 2216 | 0.750 |
Why?
|
Signal Transduction | 35 | 2019 | 11965 | 0.730 |
Why?
|
Adrenomedullin | 3 | 2012 | 104 | 0.700 |
Why?
|
Cell Transformation, Neoplastic | 8 | 2019 | 2359 | 0.700 |
Why?
|
Peptides | 6 | 2014 | 1479 | 0.690 |
Why?
|
S100 Proteins | 2 | 2012 | 181 | 0.690 |
Why?
|
Rats | 46 | 2012 | 6086 | 0.680 |
Why?
|
Cell Division | 24 | 2004 | 2489 | 0.670 |
Why?
|
Inflammation | 7 | 2024 | 2522 | 0.670 |
Why?
|
Adaptive Immunity | 1 | 2019 | 149 | 0.650 |
Why?
|
Receptors, Peptide | 2 | 2009 | 86 | 0.640 |
Why?
|
Cathepsin E | 3 | 2013 | 6 | 0.640 |
Why?
|
Gastrins | 7 | 2004 | 55 | 0.610 |
Why?
|
Pancreatic Ducts | 8 | 2020 | 122 | 0.610 |
Why?
|
Transgenes | 1 | 2019 | 557 | 0.600 |
Why?
|
ras Proteins | 5 | 2024 | 770 | 0.590 |
Why?
|
Xenograft Model Antitumor Assays | 12 | 2017 | 3821 | 0.590 |
Why?
|
Apoptosis | 14 | 2015 | 7591 | 0.580 |
Why?
|
Carbachol | 12 | 1999 | 28 | 0.580 |
Why?
|
Cell Proliferation | 25 | 2017 | 7226 | 0.570 |
Why?
|
Proto-Oncogene Proteins | 6 | 2020 | 2488 | 0.560 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 19 | 2016 | 3639 | 0.550 |
Why?
|
Proteins | 7 | 2015 | 1963 | 0.540 |
Why?
|
Calcium | 14 | 2004 | 1537 | 0.540 |
Why?
|
Diagnostic Imaging | 3 | 2014 | 1162 | 0.520 |
Why?
|
Cell Movement | 9 | 2017 | 2466 | 0.520 |
Why?
|
Drug Resistance, Multiple | 1 | 2015 | 204 | 0.520 |
Why?
|
Metaplasia | 1 | 2016 | 383 | 0.500 |
Why?
|
Ceruletide | 10 | 2016 | 27 | 0.500 |
Why?
|
Neoplasm Invasiveness | 14 | 2020 | 3981 | 0.500 |
Why?
|
Gene Expression Regulation | 14 | 2013 | 4053 | 0.500 |
Why?
|
Mice, Transgenic | 18 | 2020 | 4143 | 0.490 |
Why?
|
Stress, Physiological | 2 | 2008 | 492 | 0.480 |
Why?
|
Gene Transfer Techniques | 5 | 2019 | 716 | 0.470 |
Why?
|
Receptors, Bombesin | 5 | 1999 | 11 | 0.470 |
Why?
|
RNA Interference | 12 | 2020 | 1408 | 0.460 |
Why?
|
Cyclooxygenase 2 | 5 | 2019 | 483 | 0.460 |
Why?
|
Down-Regulation | 12 | 2020 | 2074 | 0.440 |
Why?
|
Humans | 109 | 2020 | 261506 | 0.440 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2011 | 2508 | 0.440 |
Why?
|
Cell Adhesion Molecules | 4 | 2019 | 577 | 0.440 |
Why?
|
CA-19-9 Antigen | 3 | 2008 | 144 | 0.440 |
Why?
|
Lactic Acid | 1 | 2014 | 305 | 0.430 |
Why?
|
Glucocorticoids | 9 | 1992 | 629 | 0.430 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2014 | 488 | 0.420 |
Why?
|
Neoplasms | 10 | 2019 | 15193 | 0.420 |
Why?
|
Transcription Factor RelA | 2 | 2012 | 184 | 0.420 |
Why?
|
Rats, Wistar | 10 | 2006 | 562 | 0.420 |
Why?
|
Feedback, Physiological | 2 | 2012 | 193 | 0.420 |
Why?
|
Mitogen-Activated Protein Kinases | 6 | 2008 | 639 | 0.410 |
Why?
|
Cells, Cultured | 34 | 2013 | 5637 | 0.410 |
Why?
|
Precancerous Conditions | 4 | 2020 | 1058 | 0.410 |
Why?
|
Diet, High-Fat | 3 | 2019 | 241 | 0.400 |
Why?
|
Enzyme Activation | 13 | 2011 | 1764 | 0.400 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2020 | 5178 | 0.380 |
Why?
|
Cytokines | 7 | 2017 | 2809 | 0.380 |
Why?
|
Transfection | 17 | 2014 | 2944 | 0.370 |
Why?
|
Protein Binding | 14 | 2020 | 3438 | 0.370 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 324 | 0.360 |
Why?
|
Insulin | 12 | 2012 | 1454 | 0.360 |
Why?
|
Oncogenes | 3 | 2020 | 673 | 0.360 |
Why?
|
Disease Models, Animal | 16 | 2020 | 7222 | 0.360 |
Why?
|
Mutation | 16 | 2024 | 15179 | 0.350 |
Why?
|
Tumor Cells, Cultured | 21 | 2014 | 5395 | 0.350 |
Why?
|
Gene Silencing | 4 | 2018 | 837 | 0.350 |
Why?
|
Antimetabolites, Antineoplastic | 4 | 2008 | 1299 | 0.350 |
Why?
|
Carcinoma in Situ | 2 | 2020 | 487 | 0.350 |
Why?
|
Biomarkers, Tumor | 10 | 2020 | 10331 | 0.340 |
Why?
|
Integrases | 3 | 2011 | 262 | 0.340 |
Why?
|
Neoplasm Metastasis | 8 | 2017 | 5112 | 0.330 |
Why?
|
Cation Transport Proteins | 4 | 2013 | 199 | 0.330 |
Why?
|
Blood Proteins | 2 | 2017 | 294 | 0.330 |
Why?
|
Stromal Cells | 4 | 2017 | 825 | 0.330 |
Why?
|
Antineoplastic Agents | 9 | 2020 | 14289 | 0.330 |
Why?
|
Immunohistochemistry | 17 | 2016 | 7548 | 0.330 |
Why?
|
DNA-Binding Proteins | 9 | 2009 | 4821 | 0.330 |
Why?
|
MAP Kinase Signaling System | 5 | 2020 | 848 | 0.330 |
Why?
|
Gene Expression Profiling | 12 | 2012 | 5159 | 0.330 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2008 | 129 | 0.320 |
Why?
|
Paracrine Communication | 4 | 2018 | 128 | 0.320 |
Why?
|
Lactose | 3 | 2014 | 63 | 0.310 |
Why?
|
CHO Cells | 12 | 2001 | 311 | 0.310 |
Why?
|
Up-Regulation | 8 | 2017 | 2450 | 0.300 |
Why?
|
Epidermal Growth Factor | 7 | 1995 | 423 | 0.300 |
Why?
|
Peptide Fragments | 3 | 2012 | 1271 | 0.300 |
Why?
|
Ornithine Decarboxylase | 3 | 1992 | 31 | 0.300 |
Why?
|
Peritoneal Neoplasms | 1 | 2014 | 821 | 0.300 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1999 | 206 | 0.290 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2006 | 3 | 0.290 |
Why?
|
Carcinoembryonic Antigen | 1 | 2007 | 222 | 0.290 |
Why?
|
Receptor, Cholecystokinin A | 7 | 2010 | 8 | 0.290 |
Why?
|
Dexamethasone | 12 | 1996 | 1450 | 0.290 |
Why?
|
Cricetinae | 13 | 2004 | 706 | 0.280 |
Why?
|
DNA | 15 | 1999 | 2693 | 0.280 |
Why?
|
Ligands | 7 | 2012 | 995 | 0.280 |
Why?
|
Tumor Microenvironment | 6 | 2017 | 2864 | 0.280 |
Why?
|
Genes, Reporter | 3 | 2013 | 798 | 0.280 |
Why?
|
Transforming Growth Factor beta | 5 | 2006 | 1130 | 0.280 |
Why?
|
Protein Folding | 1 | 2007 | 281 | 0.270 |
Why?
|
Blotting, Western | 14 | 2013 | 3536 | 0.270 |
Why?
|
Protein Array Analysis | 1 | 2008 | 501 | 0.270 |
Why?
|
Male | 54 | 2016 | 123000 | 0.270 |
Why?
|
Quinazolines | 1 | 2010 | 923 | 0.270 |
Why?
|
Neoplasm Transplantation | 5 | 2014 | 1519 | 0.270 |
Why?
|
Vagus Nerve | 2 | 2008 | 63 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 3552 | 0.260 |
Why?
|
Antigens, CD | 2 | 2007 | 1385 | 0.260 |
Why?
|
Chronic Disease | 6 | 2016 | 1819 | 0.260 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2020 | 650 | 0.260 |
Why?
|
Disease Progression | 10 | 2018 | 6682 | 0.260 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2020 | 703 | 0.260 |
Why?
|
Cell Survival | 8 | 2014 | 3045 | 0.260 |
Why?
|
Visceral Afferents | 1 | 2004 | 8 | 0.260 |
Why?
|
Tumor Suppressor Proteins | 2 | 2011 | 1823 | 0.260 |
Why?
|
Corticosterone | 5 | 1989 | 119 | 0.250 |
Why?
|
Transcription Factors | 7 | 2019 | 5270 | 0.250 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2013 | 568 | 0.250 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 3101 | 0.250 |
Why?
|
Ethanol | 1 | 2006 | 264 | 0.240 |
Why?
|
Kinetics | 15 | 2005 | 2049 | 0.240 |
Why?
|
Carcinoma, Acinar Cell | 3 | 2009 | 84 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 15 | 2007 | 4938 | 0.240 |
Why?
|
Time Factors | 19 | 2017 | 12926 | 0.240 |
Why?
|
Galectin 3 | 2 | 2017 | 138 | 0.240 |
Why?
|
Neovascularization, Pathologic | 5 | 2014 | 1547 | 0.230 |
Why?
|
Arginine | 2 | 2006 | 500 | 0.230 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 194 | 0.230 |
Why?
|
Islets of Langerhans | 4 | 2011 | 229 | 0.220 |
Why?
|
Chemokines | 3 | 2018 | 314 | 0.220 |
Why?
|
Thymidine | 10 | 2006 | 155 | 0.210 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2015 | 503 | 0.210 |
Why?
|
Nanoparticles | 2 | 2019 | 554 | 0.210 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 2 | 2013 | 23 | 0.210 |
Why?
|
Colonic Neoplasms | 6 | 2012 | 1390 | 0.210 |
Why?
|
Fibroblasts | 2 | 2012 | 1682 | 0.210 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2020 | 661 | 0.200 |
Why?
|
Calcium Signaling | 4 | 2011 | 284 | 0.200 |
Why?
|
Fluorine Radioisotopes | 2 | 2014 | 133 | 0.200 |
Why?
|
Trans-Activators | 4 | 2011 | 1555 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2016 | 419 | 0.200 |
Why?
|
DNA Primers | 3 | 2011 | 1399 | 0.200 |
Why?
|
I-kappa B Kinase | 2 | 2012 | 250 | 0.200 |
Why?
|
Intracellular Membranes | 1 | 2001 | 108 | 0.190 |
Why?
|
Dinoprostone | 2 | 2013 | 208 | 0.190 |
Why?
|
Cell Separation | 4 | 2005 | 612 | 0.190 |
Why?
|
Pancreatic Diseases | 2 | 2011 | 108 | 0.190 |
Why?
|
Subcellular Fractions | 2 | 2017 | 201 | 0.190 |
Why?
|
Recombinant Proteins | 10 | 2011 | 2927 | 0.180 |
Why?
|
Flow Cytometry | 4 | 2009 | 3033 | 0.180 |
Why?
|
rho GTP-Binding Proteins | 2 | 2019 | 177 | 0.180 |
Why?
|
Mutation Rate | 1 | 2020 | 223 | 0.180 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 65 | 0.180 |
Why?
|
Retinoblastoma Protein | 2 | 1999 | 335 | 0.180 |
Why?
|
Lectins, C-Type | 3 | 2011 | 162 | 0.180 |
Why?
|
Mice, Inbred C57BL | 7 | 2018 | 6942 | 0.170 |
Why?
|
Glutathione Transferase | 1 | 2020 | 359 | 0.170 |
Why?
|
Lysophospholipids | 3 | 2005 | 147 | 0.170 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2016 | 256 | 0.170 |
Why?
|
Molecular Sequence Data | 9 | 2014 | 6089 | 0.170 |
Why?
|
Drug Design | 2 | 2013 | 375 | 0.170 |
Why?
|
Base Sequence | 8 | 2011 | 4917 | 0.170 |
Why?
|
Transcription, Genetic | 5 | 2017 | 3154 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2008 | 1489 | 0.170 |
Why?
|
Lipocalin-2 | 2 | 2017 | 65 | 0.170 |
Why?
|
Culture Media, Conditioned | 3 | 2013 | 260 | 0.170 |
Why?
|
Transplantation, Heterologous | 5 | 2012 | 1082 | 0.170 |
Why?
|
Receptors, Cell Surface | 5 | 2011 | 862 | 0.170 |
Why?
|
Receptors, Adrenomedullin | 2 | 2009 | 25 | 0.170 |
Why?
|
Endocytosis | 2 | 2020 | 225 | 0.170 |
Why?
|
Adenoviridae | 9 | 2005 | 1459 | 0.160 |
Why?
|
Tissue Distribution | 2 | 2017 | 875 | 0.160 |
Why?
|
Mucoproteins | 3 | 2019 | 25 | 0.160 |
Why?
|
Immunoprecipitation | 4 | 2009 | 591 | 0.160 |
Why?
|
Fibroblast Growth Factors | 2 | 2019 | 257 | 0.160 |
Why?
|
Immune System | 2 | 2017 | 279 | 0.160 |
Why?
|
Species Specificity | 2 | 2015 | 777 | 0.160 |
Why?
|
Radiopharmaceuticals | 3 | 2014 | 1301 | 0.160 |
Why?
|
Threonine | 2 | 1995 | 161 | 0.160 |
Why?
|
Azacitidine | 1 | 2004 | 1149 | 0.160 |
Why?
|
DNA Methylation | 2 | 2007 | 2669 | 0.160 |
Why?
|
Protein Kinase C | 1 | 2000 | 396 | 0.160 |
Why?
|
GTP-Binding Proteins | 5 | 2004 | 321 | 0.160 |
Why?
|
Gastric Mucosa | 4 | 1982 | 613 | 0.160 |
Why?
|
Luciferases | 3 | 2009 | 445 | 0.160 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 153 | 0.160 |
Why?
|
Phosphorylation | 9 | 2010 | 4804 | 0.150 |
Why?
|
Antigens, Neoplasm | 4 | 2011 | 1506 | 0.150 |
Why?
|
Phenotype | 6 | 2017 | 6295 | 0.150 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 360 | 0.150 |
Why?
|
Pancreatitis-Associated Proteins | 4 | 2014 | 32 | 0.150 |
Why?
|
Genes, Retinoblastoma | 1 | 1997 | 86 | 0.150 |
Why?
|
Somatomedins | 3 | 1987 | 75 | 0.150 |
Why?
|
Biomarkers | 2 | 2008 | 5047 | 0.150 |
Why?
|
Amino Acid Sequence | 7 | 2014 | 4233 | 0.150 |
Why?
|
Integrin beta1 | 1 | 2017 | 126 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 4 | 2004 | 1555 | 0.150 |
Why?
|
MCF-7 Cells | 2 | 2019 | 550 | 0.150 |
Why?
|
Obesity | 3 | 2019 | 2884 | 0.150 |
Why?
|
Receptor, Insulin | 3 | 1989 | 97 | 0.150 |
Why?
|
NIH 3T3 Cells | 3 | 2010 | 260 | 0.140 |
Why?
|
Guanidines | 3 | 2012 | 60 | 0.140 |
Why?
|
Proteolysis | 2 | 2020 | 370 | 0.140 |
Why?
|
Membrane Proteins | 3 | 2019 | 2819 | 0.140 |
Why?
|
Epithelial Cells | 6 | 2013 | 1818 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2019 | 494 | 0.140 |
Why?
|
Microscopy, Electron | 10 | 2005 | 600 | 0.140 |
Why?
|
RNAi Therapeutics | 1 | 2016 | 42 | 0.140 |
Why?
|
Oncogene Proteins | 3 | 2019 | 354 | 0.140 |
Why?
|
Glycolysis | 1 | 2019 | 519 | 0.140 |
Why?
|
Cell Line | 13 | 2004 | 5114 | 0.140 |
Why?
|
Oocytes | 5 | 1992 | 414 | 0.140 |
Why?
|
Thiocarbamates | 3 | 2001 | 17 | 0.130 |
Why?
|
HCT116 Cells | 2 | 2014 | 348 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 7 | 2007 | 2063 | 0.130 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2015 | 83 | 0.130 |
Why?
|
Reproducibility of Results | 4 | 2008 | 6009 | 0.130 |
Why?
|
3T3 Cells | 4 | 2019 | 355 | 0.130 |
Why?
|
Gabexate | 2 | 2012 | 3 | 0.130 |
Why?
|
Regeneration | 3 | 2016 | 279 | 0.130 |
Why?
|
Smad4 Protein | 4 | 2006 | 196 | 0.130 |
Why?
|
Salivary Ducts | 1 | 2015 | 56 | 0.130 |
Why?
|
Phosphatidylinositols | 5 | 1997 | 60 | 0.130 |
Why?
|
Esters | 2 | 2012 | 45 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 4757 | 0.130 |
Why?
|
Pyrrolidines | 3 | 2001 | 113 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2001 | 1678 | 0.130 |
Why?
|
Heterografts | 2 | 2014 | 733 | 0.130 |
Why?
|
Chemokine CXCL10 | 3 | 2000 | 105 | 0.130 |
Why?
|
Antibodies, Blocking | 1 | 2015 | 91 | 0.130 |
Why?
|
Sphingosine | 2 | 2005 | 55 | 0.130 |
Why?
|
Chemokines, CXC | 3 | 2000 | 117 | 0.120 |
Why?
|
In Vitro Techniques | 5 | 2012 | 1618 | 0.120 |
Why?
|
Cell Cycle | 2 | 2002 | 2084 | 0.120 |
Why?
|
Prognosis | 7 | 2017 | 21713 | 0.120 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1993 | 20 | 0.120 |
Why?
|
Hep G2 Cells | 1 | 2014 | 155 | 0.120 |
Why?
|
Receptors, Cholinergic | 2 | 2001 | 84 | 0.120 |
Why?
|
Rats, Inbred Strains | 7 | 1992 | 410 | 0.120 |
Why?
|
Cullin Proteins | 1 | 2013 | 41 | 0.120 |
Why?
|
Endothelium, Vascular | 2 | 2009 | 891 | 0.120 |
Why?
|
Inflammation Mediators | 2 | 2017 | 423 | 0.120 |
Why?
|
Enzyme Inhibitors | 7 | 2010 | 1879 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2014 | 2173 | 0.120 |
Why?
|
Receptors, Neurotransmitter | 3 | 1988 | 27 | 0.120 |
Why?
|
Nanotechnology | 1 | 2014 | 137 | 0.120 |
Why?
|
Trypsin Inhibitors | 3 | 1990 | 18 | 0.110 |
Why?
|
Chemoprevention | 2 | 2014 | 241 | 0.110 |
Why?
|
Aminolevulinic Acid | 1 | 2013 | 19 | 0.110 |
Why?
|
Carcinogenesis | 1 | 2019 | 1026 | 0.110 |
Why?
|
F-Box Proteins | 1 | 2013 | 96 | 0.110 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1993 | 223 | 0.110 |
Why?
|
ErbB Receptors | 5 | 2015 | 2295 | 0.110 |
Why?
|
Cell Differentiation | 7 | 2013 | 4078 | 0.110 |
Why?
|
Cell Death | 2 | 2014 | 671 | 0.110 |
Why?
|
Secretory Pathway | 2 | 2011 | 16 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 585 | 0.110 |
Why?
|
Kallikreins | 2 | 1991 | 84 | 0.110 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2010 | 191 | 0.110 |
Why?
|
Drug Synergism | 4 | 2014 | 1313 | 0.110 |
Why?
|
Photochemotherapy | 1 | 2013 | 96 | 0.110 |
Why?
|
Zinc | 1 | 2013 | 188 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2013 | 630 | 0.110 |
Why?
|
HMGB1 Protein | 1 | 2012 | 37 | 0.110 |
Why?
|
S100 Calcium-Binding Protein A4 | 1 | 2012 | 57 | 0.110 |
Why?
|
Diphosphonates | 1 | 2014 | 262 | 0.110 |
Why?
|
Carcinoma | 4 | 2009 | 2578 | 0.110 |
Why?
|
Neuroglia | 2 | 2004 | 223 | 0.100 |
Why?
|
Oligonucleotide Probes | 1 | 2011 | 130 | 0.100 |
Why?
|
Trefoil Factor-1 | 1 | 2011 | 15 | 0.100 |
Why?
|
Enzyme Induction | 1 | 2012 | 249 | 0.100 |
Why?
|
Polyamines | 1 | 1992 | 75 | 0.100 |
Why?
|
Cyclic AMP | 6 | 2004 | 358 | 0.100 |
Why?
|
Energy Metabolism | 2 | 2018 | 992 | 0.100 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 171 | 0.100 |
Why?
|
Genetic Markers | 2 | 2020 | 974 | 0.100 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 634 | 0.100 |
Why?
|
Mast Cells | 1 | 2013 | 223 | 0.100 |
Why?
|
Disaccharides | 1 | 2011 | 31 | 0.100 |
Why?
|
Autoradiography | 1 | 2011 | 132 | 0.100 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2011 | 9 | 0.100 |
Why?
|
Immunoblotting | 3 | 2009 | 886 | 0.100 |
Why?
|
Prodrugs | 1 | 2013 | 217 | 0.100 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2013 | 204 | 0.100 |
Why?
|
I-kappa B Proteins | 4 | 2012 | 170 | 0.100 |
Why?
|
Heat-Shock Proteins | 2 | 2007 | 311 | 0.100 |
Why?
|
Wound Healing | 1 | 2016 | 815 | 0.100 |
Why?
|
Cytoplasm | 5 | 2020 | 652 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 476 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 200 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2012 | 154 | 0.100 |
Why?
|
Glucosides | 1 | 2011 | 64 | 0.100 |
Why?
|
Receptor, Muscarinic M3 | 3 | 1999 | 20 | 0.100 |
Why?
|
Glycosylation | 3 | 2007 | 213 | 0.100 |
Why?
|
Salivary Gland Neoplasms | 1 | 2015 | 489 | 0.100 |
Why?
|
Cell Lineage | 2 | 2011 | 668 | 0.100 |
Why?
|
Culture Techniques | 4 | 2004 | 132 | 0.090 |
Why?
|
Sodium | 4 | 1992 | 353 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 1054 | 0.090 |
Why?
|
Caveolin 1 | 1 | 2011 | 204 | 0.090 |
Why?
|
Genes, fos | 2 | 2005 | 53 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2011 | 298 | 0.090 |
Why?
|
Protein Isoforms | 3 | 2004 | 842 | 0.090 |
Why?
|
Genes | 2 | 2004 | 491 | 0.090 |
Why?
|
Cell Growth Processes | 2 | 2009 | 342 | 0.090 |
Why?
|
Adrenalectomy | 2 | 1989 | 188 | 0.090 |
Why?
|
Acute Disease | 3 | 2016 | 2422 | 0.090 |
Why?
|
In Situ Hybridization | 2 | 2002 | 1037 | 0.090 |
Why?
|
Tumor Burden | 2 | 2013 | 1987 | 0.090 |
Why?
|
Interleukin-8 | 1 | 2012 | 519 | 0.090 |
Why?
|
Culture Media | 3 | 2005 | 319 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2011 | 229 | 0.090 |
Why?
|
Cytoplasmic Granules | 2 | 1993 | 89 | 0.090 |
Why?
|
Models, Animal | 2 | 2012 | 664 | 0.090 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 424 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2000 | 226 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2011 | 185 | 0.090 |
Why?
|
Trypsin Inhibitor, Kunitz Soybean | 1 | 1989 | 4 | 0.090 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 558 | 0.090 |
Why?
|
Furin | 1 | 2009 | 10 | 0.090 |
Why?
|
Cell Culture Techniques | 3 | 2011 | 598 | 0.090 |
Why?
|
Proteomics | 2 | 2008 | 1380 | 0.090 |
Why?
|
Pancreatic Elastase | 4 | 2011 | 34 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2020 | 2054 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 4971 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 305 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2012 | 2045 | 0.080 |
Why?
|
Lipocalins | 1 | 2008 | 54 | 0.080 |
Why?
|
RNA, Transfer | 1 | 1988 | 77 | 0.080 |
Why?
|
Models, Biological | 3 | 2019 | 3254 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 79 | 0.080 |
Why?
|
Gastric Juice | 3 | 1982 | 19 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 1999 | 301 | 0.080 |
Why?
|
Serum | 1 | 2008 | 68 | 0.080 |
Why?
|
Neuropilin-2 | 1 | 2008 | 21 | 0.080 |
Why?
|
DNA, Complementary | 2 | 2003 | 869 | 0.080 |
Why?
|
Caspase 3 | 1 | 2009 | 471 | 0.080 |
Why?
|
Female | 18 | 2019 | 141928 | 0.080 |
Why?
|
Pancreatic Juice | 1 | 2007 | 13 | 0.080 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2011 | 1217 | 0.080 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2007 | 24 | 0.080 |
Why?
|
Regulatory Factor X Transcription Factors | 1 | 2007 | 24 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2007 | 25 | 0.080 |
Why?
|
Cell Hypoxia | 2 | 2008 | 328 | 0.080 |
Why?
|
Plasma | 1 | 2008 | 158 | 0.080 |
Why?
|
Paclitaxel | 1 | 2014 | 1996 | 0.080 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 324 | 0.080 |
Why?
|
X-Box Binding Protein 1 | 1 | 2007 | 38 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1077 | 0.070 |
Why?
|
Calcimycin | 4 | 2002 | 48 | 0.070 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 57 | 0.070 |
Why?
|
Mesoderm | 1 | 2009 | 404 | 0.070 |
Why?
|
MicroRNAs | 2 | 2013 | 2947 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 778 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 3578 | 0.070 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 122 | 0.070 |
Why?
|
Epithelium | 1 | 2009 | 720 | 0.070 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2008 | 196 | 0.070 |
Why?
|
Mice, SCID | 2 | 2011 | 1869 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1832 | 0.070 |
Why?
|
Second Messenger Systems | 2 | 1997 | 39 | 0.070 |
Why?
|
GPI-Linked Proteins | 2 | 2019 | 223 | 0.070 |
Why?
|
Pericytes | 1 | 2007 | 96 | 0.070 |
Why?
|
Receptors, Glucocorticoid | 1 | 1988 | 192 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2009 | 397 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 5 | 2002 | 1062 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2012 | 731 | 0.070 |
Why?
|
Imidazoles | 1 | 2012 | 999 | 0.070 |
Why?
|
Activating Transcription Factor 3 | 1 | 2006 | 31 | 0.070 |
Why?
|
Genes, APC | 1 | 2006 | 70 | 0.070 |
Why?
|
Muscle Proteins | 1 | 2010 | 549 | 0.070 |
Why?
|
Gastrointestinal Agents | 1 | 1987 | 108 | 0.070 |
Why?
|
Receptor, Cholecystokinin B | 3 | 1998 | 4 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2011 | 2292 | 0.070 |
Why?
|
Type C Phospholipases | 4 | 2005 | 53 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2015 | 4367 | 0.070 |
Why?
|
Guanosine Triphosphate | 2 | 2024 | 90 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2009 | 528 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 1399 | 0.070 |
Why?
|
eIF-2 Kinase | 1 | 2007 | 164 | 0.070 |
Why?
|
Biological Transport | 4 | 2004 | 597 | 0.070 |
Why?
|
Molecular Chaperones | 1 | 2007 | 264 | 0.070 |
Why?
|
beta-Galactosidase | 3 | 2006 | 211 | 0.070 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 205 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 589 | 0.070 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2005 | 261 | 0.070 |
Why?
|
Culture Media, Serum-Free | 1 | 2005 | 74 | 0.070 |
Why?
|
Glycation End Products, Advanced | 1 | 2005 | 31 | 0.070 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2006 | 161 | 0.070 |
Why?
|
Guinea Pigs | 4 | 2004 | 241 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 1265 | 0.070 |
Why?
|
Neurotransmitter Agents | 2 | 2004 | 159 | 0.070 |
Why?
|
GTPase-Activating Proteins | 1 | 2006 | 126 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2010 | 1038 | 0.070 |
Why?
|
Secretory Vesicles | 1 | 2005 | 39 | 0.060 |
Why?
|
Phorbols | 1 | 1984 | 9 | 0.060 |
Why?
|
RNA Splicing | 1 | 2007 | 370 | 0.060 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2005 | 80 | 0.060 |
Why?
|
Nodose Ganglion | 1 | 2004 | 6 | 0.060 |
Why?
|
beta Catenin | 1 | 2009 | 688 | 0.060 |
Why?
|
Fibrosis | 3 | 2013 | 793 | 0.060 |
Why?
|
Cholinergic Fibers | 1 | 2004 | 11 | 0.060 |
Why?
|
Phorbol Esters | 1 | 1984 | 39 | 0.060 |
Why?
|
Sarcoma | 1 | 2015 | 1725 | 0.060 |
Why?
|
Androgen-Binding Protein | 1 | 2004 | 39 | 0.060 |
Why?
|
N-Methylscopolamine | 2 | 1999 | 3 | 0.060 |
Why?
|
Antibodies, Neutralizing | 2 | 2019 | 541 | 0.060 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2004 | 27 | 0.060 |
Why?
|
Tritium | 3 | 1993 | 200 | 0.060 |
Why?
|
Insulinoma | 1 | 2004 | 55 | 0.060 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2007 | 584 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 15862 | 0.060 |
Why?
|
Postprandial Period | 1 | 2004 | 85 | 0.060 |
Why?
|
Reference Values | 4 | 1997 | 1099 | 0.060 |
Why?
|
Myenteric Plexus | 1 | 2004 | 18 | 0.060 |
Why?
|
Tamoxifen | 1 | 2008 | 876 | 0.060 |
Why?
|
Calreticulin | 1 | 2004 | 74 | 0.060 |
Why?
|
Cloning, Molecular | 5 | 1996 | 1213 | 0.060 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2004 | 34 | 0.060 |
Why?
|
Coculture Techniques | 2 | 2017 | 626 | 0.060 |
Why?
|
Estrenes | 4 | 2005 | 24 | 0.060 |
Why?
|
Ionophores | 2 | 2002 | 22 | 0.060 |
Why?
|
Egtazic Acid | 2 | 2000 | 54 | 0.060 |
Why?
|
Enteric Nervous System | 1 | 2004 | 36 | 0.060 |
Why?
|
Taurocholic Acid | 1 | 2003 | 13 | 0.060 |
Why?
|
ROC Curve | 1 | 2007 | 1183 | 0.060 |
Why?
|
Fluorouracil | 2 | 2009 | 1944 | 0.060 |
Why?
|
Aldosterone | 3 | 1991 | 72 | 0.060 |
Why?
|
Devazepide | 3 | 1997 | 5 | 0.060 |
Why?
|
Growth Substances | 1 | 2004 | 300 | 0.060 |
Why?
|
Benzodiazepinones | 3 | 1997 | 12 | 0.060 |
Why?
|
Smad3 Protein | 2 | 2004 | 129 | 0.060 |
Why?
|
Xenopus laevis | 5 | 1992 | 270 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2010 | 371 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2009 | 1048 | 0.060 |
Why?
|
Exocytosis | 3 | 2008 | 111 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 1258 | 0.060 |
Why?
|
STAT3 Transcription Factor | 1 | 2010 | 1121 | 0.060 |
Why?
|
Serotonin | 1 | 2004 | 264 | 0.060 |
Why?
|
Colony-Forming Units Assay | 2 | 2010 | 249 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 234 | 0.060 |
Why?
|
Early Growth Response Protein 1 | 1 | 2003 | 67 | 0.060 |
Why?
|
Cyclin D1 | 2 | 2010 | 576 | 0.060 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 246 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 314 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2003 | 107 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1984 | 224 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2004 | 198 | 0.050 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1998 | 600 | 0.050 |
Why?
|
Neural Pathways | 1 | 2004 | 298 | 0.050 |
Why?
|
Poly A | 3 | 1992 | 87 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 280 | 0.050 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2002 | 14 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2017 | 5710 | 0.050 |
Why?
|
Ionomycin | 2 | 2000 | 34 | 0.050 |
Why?
|
Amphibians | 1 | 1982 | 7 | 0.050 |
Why?
|
DNA Probes | 3 | 1992 | 217 | 0.050 |
Why?
|
Pyrrolidinones | 3 | 2005 | 61 | 0.050 |
Why?
|
Leucine | 3 | 1992 | 352 | 0.050 |
Why?
|
CpG Islands | 1 | 2004 | 633 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 1362 | 0.050 |
Why?
|
Odds Ratio | 1 | 2007 | 2316 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2004 | 264 | 0.050 |
Why?
|
Genes, Dominant | 2 | 2001 | 331 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2004 | 297 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2012 | 6100 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2006 | 363 | 0.050 |
Why?
|
Cell Membrane | 4 | 2005 | 850 | 0.050 |
Why?
|
Cyclins | 2 | 2001 | 456 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2013 | 518 | 0.050 |
Why?
|
Inositol Phosphates | 2 | 2005 | 23 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2000 | 1620 | 0.050 |
Why?
|
Adenoma | 1 | 2006 | 716 | 0.050 |
Why?
|
Progesterone | 3 | 1991 | 513 | 0.050 |
Why?
|
Hydrolysis | 3 | 1995 | 227 | 0.050 |
Why?
|
Autoantibodies | 1 | 2004 | 576 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2000 | 997 | 0.050 |
Why?
|
Maleimides | 1 | 2000 | 22 | 0.050 |
Why?
|
Smad2 Protein | 1 | 2000 | 89 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2020 | 32 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2001 | 143 | 0.050 |
Why?
|
NF-KappaB Inhibitor alpha | 2 | 2012 | 136 | 0.050 |
Why?
|
Blotting, Northern | 3 | 2005 | 682 | 0.040 |
Why?
|
Logistic Models | 1 | 2007 | 3441 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 81 | 0.040 |
Why?
|
Genes, src | 1 | 1999 | 27 | 0.040 |
Why?
|
Collagen | 2 | 2016 | 752 | 0.040 |
Why?
|
Aorta | 1 | 2004 | 692 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2006 | 1129 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 5539 | 0.040 |
Why?
|
Enzyme Precursors | 2 | 1996 | 66 | 0.040 |
Why?
|
Aerobiosis | 1 | 2019 | 30 | 0.040 |
Why?
|
Drug Interactions | 2 | 2005 | 553 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 95 | 0.040 |
Why?
|
Liposomes | 2 | 2014 | 684 | 0.040 |
Why?
|
Endosomes | 1 | 2020 | 109 | 0.040 |
Why?
|
Chelating Agents | 1 | 2000 | 127 | 0.040 |
Why?
|
Homeodomain Proteins | 3 | 2011 | 1143 | 0.040 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2018 | 9 | 0.040 |
Why?
|
Intracellular Fluid | 2 | 2011 | 45 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 259 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2018 | 84 | 0.040 |
Why?
|
Carcinogens | 1 | 2000 | 384 | 0.040 |
Why?
|
Ribonucleases | 2 | 1989 | 88 | 0.040 |
Why?
|
Lac Operon | 2 | 2011 | 122 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6207 | 0.040 |
Why?
|
Pancreatic Cyst | 1 | 2019 | 107 | 0.040 |
Why?
|
Lung | 1 | 2009 | 3151 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 4892 | 0.040 |
Why?
|
PPAR gamma | 1 | 2019 | 229 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 134 | 0.040 |
Why?
|
Cattle | 2 | 1997 | 783 | 0.040 |
Why?
|
Rana pipiens | 3 | 1982 | 15 | 0.040 |
Why?
|
Protein Biosynthesis | 3 | 1988 | 889 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2018 | 299 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 182 | 0.040 |
Why?
|
Chymotrypsin | 2 | 1989 | 39 | 0.040 |
Why?
|
Clone Cells | 1 | 1999 | 555 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2020 | 613 | 0.040 |
Why?
|
Aged | 7 | 2016 | 70117 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2018 | 1439 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 7551 | 0.040 |
Why?
|
Macromolecular Substances | 3 | 2005 | 293 | 0.040 |
Why?
|
Protein Transport | 1 | 2020 | 734 | 0.040 |
Why?
|
Galectins | 1 | 2017 | 71 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 1997 | 118 | 0.040 |
Why?
|
Ubiquitination | 1 | 2020 | 575 | 0.040 |
Why?
|
Cathepsin B | 1 | 1996 | 32 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 1997 | 203 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2010 | 611 | 0.040 |
Why?
|
Structure-Activity Relationship | 2 | 1996 | 931 | 0.040 |
Why?
|
Receptors, Somatotropin | 1 | 1996 | 17 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 5767 | 0.040 |
Why?
|
Indoles | 2 | 2000 | 1009 | 0.040 |
Why?
|
Middle Aged | 7 | 2016 | 86204 | 0.040 |
Why?
|
Anisomycin | 1 | 1996 | 11 | 0.040 |
Why?
|
Mice, Inbred ICR | 2 | 2010 | 239 | 0.040 |
Why?
|
Protein Kinases | 2 | 1999 | 874 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 315 | 0.030 |
Why?
|
Binding Sites | 5 | 2005 | 2171 | 0.030 |
Why?
|
Muscarinic Agonists | 1 | 1995 | 40 | 0.030 |
Why?
|
United States | 2 | 2018 | 15433 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 1997 | 190 | 0.030 |
Why?
|
Submandibular Gland | 1 | 2015 | 20 | 0.030 |
Why?
|
Growth Hormone | 1 | 1996 | 226 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2015 | 29902 | 0.030 |
Why?
|
Bromodeoxyuridine | 2 | 2006 | 139 | 0.030 |
Why?
|
Nucleotides | 1 | 1996 | 164 | 0.030 |
Why?
|
Antimetabolites | 2 | 2006 | 69 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 448 | 0.030 |
Why?
|
Receptors, Neuropeptide | 1 | 1995 | 27 | 0.030 |
Why?
|
Albumins | 2 | 2014 | 258 | 0.030 |
Why?
|
Integrin beta Chains | 1 | 2015 | 34 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 394 | 0.030 |
Why?
|
Adult | 5 | 2016 | 77950 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 701 | 0.030 |
Why?
|
Extracellular Space | 1 | 2015 | 132 | 0.030 |
Why?
|
Pertussis Toxin | 2 | 2005 | 57 | 0.030 |
Why?
|
Laminin | 1 | 2015 | 194 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2011 | 2314 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2009 | 287 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2009 | 1053 | 0.030 |
Why?
|
Postmenopause | 1 | 2016 | 378 | 0.030 |
Why?
|
Nanomedicine | 1 | 2014 | 54 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1165 | 0.030 |
Why?
|
Thapsigargin | 1 | 1993 | 38 | 0.030 |
Why?
|
Binding, Competitive | 3 | 1996 | 300 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 2014 | 148 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1986 | 220 | 0.030 |
Why?
|
Calcium-Transporting ATPases | 1 | 1993 | 60 | 0.030 |
Why?
|
Terpenes | 1 | 1993 | 34 | 0.030 |
Why?
|
Cetuximab | 1 | 2015 | 472 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 2 | 1995 | 1756 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 1995 | 360 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2016 | 551 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2013 | 311 | 0.030 |
Why?
|
Tryptases | 1 | 2013 | 48 | 0.030 |
Why?
|
Cell Degranulation | 1 | 2013 | 47 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 1997 | 580 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2014 | 202 | 0.030 |
Why?
|
Benzylamines | 1 | 2013 | 105 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 9180 | 0.030 |
Why?
|
Caloric Restriction | 1 | 2013 | 88 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2006 | 184 | 0.030 |
Why?
|
Genes, jun | 1 | 1992 | 41 | 0.030 |
Why?
|
Lipase | 1 | 1993 | 112 | 0.030 |
Why?
|
Smoothened Receptor | 1 | 2012 | 52 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2013 | 135 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 1993 | 3203 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 59 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2013 | 119 | 0.030 |
Why?
|
Naphthalenes | 1 | 2013 | 83 | 0.030 |
Why?
|
Cdc20 Proteins | 1 | 2012 | 25 | 0.030 |
Why?
|
Chymotrypsinogen | 1 | 1992 | 2 | 0.030 |
Why?
|
Lysophospholipase | 1 | 1992 | 4 | 0.030 |
Why?
|
Organ Size | 2 | 2010 | 690 | 0.030 |
Why?
|
Ornithine Decarboxylase Inhibitors | 1 | 1992 | 15 | 0.030 |
Why?
|
Chromaffin Granules | 1 | 1992 | 2 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 214 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 1995 | 741 | 0.030 |
Why?
|
Collagen Type I | 1 | 2013 | 204 | 0.030 |
Why?
|
Light | 1 | 2013 | 245 | 0.030 |
Why?
|
Anticarcinogenic Agents | 1 | 2014 | 362 | 0.030 |
Why?
|
Substance P | 2 | 1995 | 71 | 0.030 |
Why?
|
Eflornithine | 1 | 1992 | 59 | 0.030 |
Why?
|
Biological Transport, Active | 2 | 1982 | 131 | 0.030 |
Why?
|
Genetic Vectors | 1 | 1997 | 1694 | 0.030 |
Why?
|
Heparin-binding EGF-like Growth Factor | 1 | 2011 | 21 | 0.030 |
Why?
|
Halogenation | 1 | 2011 | 14 | 0.030 |
Why?
|
Receptors, Histamine H2 | 1 | 1991 | 12 | 0.030 |
Why?
|
Adiposity | 1 | 2013 | 237 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 1997 | 1910 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1992 | 334 | 0.030 |
Why?
|
Comorbidity | 1 | 2018 | 2352 | 0.030 |
Why?
|
Forkhead Box Protein M1 | 1 | 2011 | 113 | 0.030 |
Why?
|
Gene Deletion | 1 | 2016 | 1442 | 0.030 |
Why?
|
Receptor, PAR-2 | 1 | 2011 | 6 | 0.020 |
Why?
|
Receptors, Histamine H1 | 1 | 1991 | 7 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2010 | 15694 | 0.020 |
Why?
|
Diphtheria Toxin | 1 | 2011 | 81 | 0.020 |
Why?
|
Blood Vessels | 1 | 2012 | 217 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2007 | 4638 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2013 | 269 | 0.020 |
Why?
|
Receptor, PAR-1 | 1 | 2011 | 33 | 0.020 |
Why?
|
Liver Regeneration | 1 | 2011 | 134 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 392 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 461 | 0.020 |
Why?
|
Genes, myc | 1 | 1992 | 358 | 0.020 |
Why?
|
Hydroxyurea | 1 | 1991 | 204 | 0.020 |
Why?
|
Biomedical Research | 1 | 2018 | 806 | 0.020 |
Why?
|
Somatostatin | 2 | 1988 | 114 | 0.020 |
Why?
|
Pancreatic Hormones | 1 | 1990 | 8 | 0.020 |
Why?
|
Body Composition | 1 | 2013 | 595 | 0.020 |
Why?
|
Macrophages | 1 | 2016 | 1304 | 0.020 |
Why?
|
Cell Communication | 1 | 2013 | 509 | 0.020 |
Why?
|
Calcineurin Inhibitors | 1 | 2010 | 68 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 96 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 669 | 0.020 |
Why?
|
Risk Factors | 2 | 2018 | 17523 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 760 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 548 | 0.020 |
Why?
|
Calcineurin | 1 | 2010 | 128 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 212 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2011 | 237 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
Dishevelled Proteins | 1 | 2009 | 59 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 459 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2010 | 210 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 905 | 0.020 |
Why?
|
Blood Glucose | 1 | 2013 | 1244 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 3719 | 0.020 |
Why?
|
Tacrolimus | 1 | 2010 | 335 | 0.020 |
Why?
|
Zinc Finger E-box-Binding Homeobox 1 | 1 | 2009 | 159 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1988 | 17 | 0.020 |
Why?
|
Phosphoproteins | 2 | 2009 | 1152 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 460 | 0.020 |
Why?
|
Microvilli | 1 | 1988 | 83 | 0.020 |
Why?
|
Food | 1 | 1989 | 146 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1993 | 1073 | 0.020 |
Why?
|
Puromycin | 1 | 1987 | 15 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1989 | 542 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 750 | 0.020 |
Why?
|
Semaphorins | 1 | 2008 | 38 | 0.020 |
Why?
|
Cycloheximide | 1 | 1987 | 97 | 0.020 |
Why?
|
Permeability | 1 | 1988 | 167 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1991 | 544 | 0.020 |
Why?
|
Half-Life | 1 | 1988 | 259 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2010 | 11538 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 197 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 943 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 125 | 0.020 |
Why?
|
Histamine | 2 | 1991 | 53 | 0.020 |
Why?
|
Bethanechol Compounds | 1 | 1986 | 2 | 0.020 |
Why?
|
Bethanechol | 1 | 1986 | 2 | 0.020 |
Why?
|
Methacholine Compounds | 1 | 1986 | 2 | 0.020 |
Why?
|
Parasympatholytics | 1 | 1986 | 12 | 0.020 |
Why?
|
Methacholine Chloride | 1 | 1986 | 29 | 0.020 |
Why?
|
Scopolamine Derivatives | 1 | 1986 | 15 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1987 | 107 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1986 | 25 | 0.020 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 60 | 0.020 |
Why?
|
Secretory Rate | 1 | 1986 | 16 | 0.020 |
Why?
|
Kidney | 1 | 1995 | 2146 | 0.020 |
Why?
|
Tyrosine | 2 | 1999 | 498 | 0.020 |
Why?
|
Glucose | 1 | 2012 | 1248 | 0.020 |
Why?
|
Cadherins | 1 | 2009 | 660 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2011 | 973 | 0.020 |
Why?
|
Hypertrophy | 1 | 2006 | 162 | 0.020 |
Why?
|
Liver | 2 | 2013 | 2961 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2006 | 213 | 0.020 |
Why?
|
Purines | 1 | 2007 | 273 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2008 | 1008 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 241 | 0.020 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2006 | 146 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2005 | 27 | 0.020 |
Why?
|
Dibutyryl Cyclic GMP | 1 | 1984 | 4 | 0.020 |
Why?
|
Immunotherapy | 1 | 2018 | 3341 | 0.020 |
Why?
|
Phosphatidylethanolamine Binding Protein | 1 | 2004 | 7 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 52 | 0.020 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 2004 | 17 | 0.020 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2005 | 66 | 0.020 |
Why?
|
Microdissection | 1 | 2004 | 86 | 0.020 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2004 | 42 | 0.020 |
Why?
|
rac GTP-Binding Proteins | 1 | 2004 | 39 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2011 | 941 | 0.020 |
Why?
|
Bortezomib | 1 | 2006 | 543 | 0.020 |
Why?
|
Boronic Acids | 1 | 2006 | 362 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 1984 | 70 | 0.020 |
Why?
|
COS Cells | 1 | 2005 | 377 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2005 | 289 | 0.020 |
Why?
|
Receptors, Lysophospholipid | 1 | 2004 | 3 | 0.020 |
Why?
|
Thermodynamics | 1 | 1984 | 196 | 0.020 |
Why?
|
Integrins | 1 | 2006 | 262 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 336 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 43 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 602 | 0.010 |
Why?
|
Phosphates | 1 | 2005 | 187 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1984 | 521 | 0.010 |
Why?
|
Sphingolipids | 1 | 2004 | 38 | 0.010 |
Why?
|
Appetite Depressants | 1 | 1983 | 21 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 49 | 0.010 |
Why?
|
Pyrazines | 1 | 2006 | 495 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 478 | 0.010 |
Why?
|
Cytosol | 1 | 2004 | 238 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 1996 | 571 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 2004 | 324 | 0.010 |
Why?
|
Temperature | 1 | 1984 | 506 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 1996 | 28 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 261 | 0.010 |
Why?
|
Protein Subunits | 1 | 2004 | 274 | 0.010 |
Why?
|
Algorithms | 2 | 2004 | 3890 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2086 | 0.010 |
Why?
|
Calcium Channels | 1 | 2004 | 197 | 0.010 |
Why?
|
Lysine | 1 | 2005 | 422 | 0.010 |
Why?
|
Ouabain | 1 | 1982 | 40 | 0.010 |
Why?
|
Microinjections | 2 | 1992 | 96 | 0.010 |
Why?
|
Mitosis | 1 | 2005 | 615 | 0.010 |
Why?
|
Estradiol | 1 | 1986 | 748 | 0.010 |
Why?
|
Protein Precursors | 1 | 2004 | 240 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 837 | 0.010 |
Why?
|
Rana catesbeiana | 1 | 1982 | 3 | 0.010 |
Why?
|
Freeze Fracturing | 1 | 1982 | 6 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 2004 | 336 | 0.010 |
Why?
|
Diet | 1 | 2010 | 1440 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1981 | 14 | 0.010 |
Why?
|
Bucladesine | 1 | 1981 | 31 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 4320 | 0.010 |
Why?
|
Cisplatin | 1 | 2009 | 2432 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 671 | 0.010 |
Why?
|
Chlorides | 1 | 1982 | 139 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2004 | 702 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 1064 | 0.010 |
Why?
|
Genetic Therapy | 1 | 2009 | 1616 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 6869 | 0.010 |
Why?
|
Protein Conformation | 1 | 2005 | 1258 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 10001 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 1533 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 12873 | 0.010 |
Why?
|
Mitochondria | 1 | 1988 | 1282 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2002 | 205 | 0.010 |
Why?
|
Potassium | 1 | 1982 | 329 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1982 | 426 | 0.010 |
Why?
|
Rabbits | 1 | 1982 | 957 | 0.010 |
Why?
|
Dogs | 2 | 1993 | 1155 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1981 | 424 | 0.010 |
Why?
|
DNA, Antisense | 1 | 1999 | 42 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 1732 | 0.010 |
Why?
|
Butadienes | 1 | 1999 | 35 | 0.010 |
Why?
|
Pyridines | 1 | 2006 | 1244 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 591 | 0.010 |
Why?
|
Mifepristone | 2 | 1991 | 147 | 0.010 |
Why?
|
Lymphoma | 1 | 1988 | 1467 | 0.010 |
Why?
|
MAP Kinase Kinase 4 | 1 | 1999 | 142 | 0.010 |
Why?
|
Fetus | 1 | 1982 | 601 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2001 | 534 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 4975 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 4109 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 7702 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1999 | 726 | 0.010 |
Why?
|
Molecular Weight | 2 | 1988 | 629 | 0.010 |
Why?
|
Receptors, Somatostatin | 2 | 1988 | 85 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 3472 | 0.010 |
Why?
|
Software | 1 | 2005 | 1321 | 0.010 |
Why?
|
MAP Kinase Kinase Kinase 4 | 1 | 1997 | 3 | 0.010 |
Why?
|
Genes, p53 | 1 | 2002 | 1090 | 0.010 |
Why?
|
Nucleoside-Diphosphate Kinase | 1 | 1996 | 13 | 0.010 |
Why?
|
Cell-Free System | 1 | 1996 | 150 | 0.010 |
Why?
|
Antibodies | 1 | 1999 | 838 | 0.010 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1995 | 5 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4557 | 0.010 |
Why?
|
Bradykinin | 1 | 1995 | 79 | 0.010 |
Why?
|
Nitriles | 1 | 1999 | 906 | 0.010 |
Why?
|
Oligopeptides | 1 | 1997 | 429 | 0.010 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1995 | 163 | 0.010 |
Why?
|
Neuropeptides | 1 | 1995 | 154 | 0.010 |
Why?
|
Glioma | 1 | 2005 | 1963 | 0.010 |
Why?
|
Horses | 1 | 1993 | 96 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 264 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1992 | 21 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 32848 | 0.010 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 1992 | 38 | 0.010 |
Why?
|
Biological Evolution | 1 | 1993 | 278 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1992 | 549 | 0.010 |
Why?
|
Cimetidine | 1 | 1991 | 28 | 0.010 |
Why?
|
Diphenhydramine | 1 | 1991 | 21 | 0.010 |
Why?
|
Norepinephrine | 1 | 1992 | 272 | 0.010 |
Why?
|
Parietal Cells, Gastric | 1 | 1991 | 37 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 354 | 0.010 |
Why?
|
Hormones | 1 | 1991 | 266 | 0.010 |
Why?
|
Swine | 1 | 1993 | 1541 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1988 | 57 | 0.010 |
Why?
|
Pregnancy | 1 | 1982 | 7573 | 0.010 |
Why?
|
Exocrine Glands | 1 | 1988 | 15 | 0.010 |
Why?
|
Hybridomas | 1 | 1988 | 75 | 0.010 |
Why?
|
Adenylyl Cyclases | 1 | 1988 | 87 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1988 | 185 | 0.000 |
Why?
|
Feedback | 1 | 1989 | 198 | 0.000 |
Why?
|
Hemin | 1 | 1987 | 24 | 0.000 |
Why?
|
Methionine | 1 | 1987 | 159 | 0.000 |
Why?
|
Immunization | 1 | 1988 | 397 | 0.000 |
Why?
|
RNA | 1 | 1991 | 1013 | 0.000 |
Why?
|
Intestine, Small | 1 | 1988 | 499 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 5437 | 0.000 |
Why?
|